Description
Description
Solensia is a monoclonal antibody (mAb) for the control of osteoarthritis pain in cats. Solensia targets Nerve Growth Factor, a highly specific protein targeting molecules involved in disease. It functions like naturally occurring antibodies—it is eliminated via normal protein degradation pathways, with minimal involvement of the liver or kidneys
Benefits
- Once-monthly monoclonal antibody therapy, for the control of feline osteoarthritis (OA) pain, administered by a veterinarian.
- 77% of cat owners reported improvement in signs of pain when their cats were treated monthly with Solensia in a 3-month study.
- Controls the pain of OA in cats, helping to improve their mobility, comfort and well-being.
Awesome job packing & shipping our refrigerated item.
Super good prescription drug pricing.